Description

(20R)-3α-[[(E)-3-(4-Hydroxyphenyl)-1-Oxo-2-Propenyl]Oxy]-D:C-Friedoolean-7,9(11)-Dien-29-Oic Acid is a complex triterpenoid derivative of significant interest in advanced pharmaceutical and biochemical research. This compound matters as a high-purity, structurally defined intermediate for the development of novel therapeutic agents and bioactive molecules. It is primarily needed by research institutions, pharmaceutical R&D departments, and fine chemical manufacturers focused on anti-inflammatory, anticancer, or metabolic pathway modulation studies.

Application

• Pharmaceutical Intermediate: Serves as a key synthetic precursor or active pharmaceutical ingredient (API) in the development of novel therapeutic compounds.
• Biochemical Research: Used as a reference standard or probe in studies investigating enzyme inhibition, receptor binding, and cellular signaling pathways.
• Natural Product Synthesis: Acts as a sophisticated building block for the semi-synthesis or total synthesis of complex natural products and their analogs.
• Anti-inflammatory Agent Development: Investigated for its potential biological activity in modulating inflammatory responses, given its triterpenoid core structure.
• Academic & Industrial R&D: Employed in discovery chemistry and medicinal chemistry programs for structure-activity relationship (SAR) studies.
• High-Purity Reference Material: Supplied as a certified reference material (CRM) for analytical method development and validation in quality control laboratories.

Basic Information

Product Name	(20R)-3α-[[(E)-3-(4-Hydroxyphenyl)-1-Oxo-2-Propenyl]Oxy]-D:C-Friedoolean-7,9(11)-Dien-29-Oic Acid
CAS No.	76475-14-4
Molecular Formula	C39H50O5
Molecular Weight	598.82 g/mol
Synonyms	3α-[(E)-3-(4-Hydroxyphenyl)acryloyloxy]friedel-7,9(11)-dien-29-oic acid; (20R)-3α-[[(E)-3-(4-Hydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]friedoolean-7,9(11)-dien-29-oic acid; Friedoolean-7,9(11)-dien-29-oic acid, 3α-[[(E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]-, (20R)-; Triterpenoid caffeate derivative; 3α-O-Caffeoylfriedoolean-7,9(11)-dien-29-oic acid; 76475-14-4; (20R)-3α-(4-Hydroxycinnamoyloxy)friedel-7,9(11)-dien-29-oic acid
EINECS	Contact for details

Quality Control

Our (20R)-3α-[[(E)-3-(4-Hydroxyphenyl)-1-Oxo-2-Propenyl]Oxy]-D:C-Friedoolean-7,9(11)-Dien-29-Oic Acid is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure high purity and structural identity. Certificates of Analysis (COA) detailing purity, impurities, and analytical results are provided and can be tailored to meet specific research or regulatory requirements.

Storage

Preserve in a tightly closed container, protected from light. Store at controlled room temperature (15-25°C) in a dry, well-ventilated area. Keep the container sealed to protect from moisture and contamination.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Loss on Drying	≤ 2.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.